NZ600094A - Method of enhancing muscle protein synthesis - Google Patents

Method of enhancing muscle protein synthesis

Info

Publication number
NZ600094A
NZ600094A NZ600094A NZ60009410A NZ600094A NZ 600094 A NZ600094 A NZ 600094A NZ 600094 A NZ600094 A NZ 600094A NZ 60009410 A NZ60009410 A NZ 60009410A NZ 600094 A NZ600094 A NZ 600094A
Authority
NZ
New Zealand
Prior art keywords
range
present
protein synthesis
composition
amount
Prior art date
Application number
NZ600094A
Other languages
English (en)
Inventor
John Alan Hawley
Daniel Ryan Moore
Trent Stellingwerff
Louise Mary Burke
Eric Zaltas
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of NZ600094A publication Critical patent/NZ600094A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ600094A 2009-11-29 2010-11-29 Method of enhancing muscle protein synthesis NZ600094A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09177423.2A EP2327316B1 (en) 2009-11-29 2009-11-29 Method of enhancing muscle protein synthesis
PCT/EP2010/068439 WO2011064373A1 (en) 2009-11-29 2010-11-29 Method of enhancing muscle protein synthesis

Publications (1)

Publication Number Publication Date
NZ600094A true NZ600094A (en) 2014-10-31

Family

ID=42135915

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ600094A NZ600094A (en) 2009-11-29 2010-11-29 Method of enhancing muscle protein synthesis

Country Status (13)

Country Link
US (1) US20130203645A1 (enExample)
EP (1) EP2327316B1 (enExample)
JP (1) JP5810429B2 (enExample)
CN (1) CN102665445B (enExample)
AU (1) AU2010323089B2 (enExample)
BR (1) BR112012012811A2 (enExample)
CA (1) CA2781764A1 (enExample)
IN (1) IN2012DN04085A (enExample)
MX (1) MX2012005646A (enExample)
NZ (1) NZ600094A (enExample)
PH (1) PH12012500875A1 (enExample)
RU (1) RU2503269C1 (enExample)
WO (1) WO2011064373A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016472B2 (en) 2012-06-11 2018-07-10 William J. Kraemer Methods of mitigating the negative effects of resistance exercise
US20150150898A1 (en) * 2012-06-11 2015-06-04 Nu Science Laboratories, Inc. Nutritional products and methods of improving exercise performance and reducing exercise induced impairment of immune function
CA2892021A1 (en) * 2012-11-20 2014-05-30 Pronutria, Inc. Engineered secreted proteins and methods
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CN105101812B (zh) 2013-03-08 2018-04-10 艾斯姆食品公司 大米蛋白补充剂
AU2014242565A1 (en) * 2013-03-26 2015-10-15 Premier Nutrition Corporation Methods for enhancing muscle protein synthesis following concurrent training
US10271570B2 (en) 2013-08-15 2019-04-30 Nu Science Laboratories, Inc. Compositions for and methods of diet supplementation
WO2015040533A1 (en) * 2013-09-19 2015-03-26 Premier Nutrition Corporation Methods for enhancing muscle protein synthesis during energy deficit
PL238958B1 (pl) * 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
SG11202001142VA (en) 2017-08-14 2020-03-30 Axcella Health Inc Amino acid compositions for the treatment of liver disease
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1075713C (zh) * 1996-05-23 2001-12-05 大塚制药株式会社 降低身体脂肪含量和改善身体组成的食物组合物及其方法
US6013290A (en) * 1997-11-17 2000-01-11 Weinstein; Robert E. Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise
ATE320724T1 (de) * 1999-12-30 2006-04-15 Kerry Group Services Ltd Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichung
US20020119928A1 (en) * 2000-10-27 2002-08-29 Mcanalley Bill H. Dietary supplement compositions
US7740893B2 (en) * 2001-04-02 2010-06-22 Mott's Llp Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US20030064134A1 (en) * 2001-10-03 2003-04-03 Eastman Outdoors Kit, system and method for preparing home-made nutritional food items
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
JP2005070853A (ja) * 2003-08-26 2005-03-17 Md 21:Kk ダイエットプログラムのメニュー作成方法及びそのシステム
US7205018B2 (en) * 2004-10-07 2007-04-17 Next Proteins, Inc. Carbonated protein drink and method of making
WO2007006135A1 (en) * 2005-07-07 2007-01-18 H3 Formulations Ltd. Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells
WO2007056176A2 (en) * 2005-11-03 2007-05-18 Southwest Immunology, Inc. Compositions for preventing and reducing delayed onset muscle soreness
US20070243290A1 (en) * 2006-04-18 2007-10-18 Melody Thompson Method of tailoring infant formulas to individual nutritional needs prior to use
US20070270355A1 (en) * 2006-05-11 2007-11-22 Garcia Ramon D Sport drink containing amino acids and carbohydrates
RU2306720C1 (ru) * 2006-07-06 2007-09-27 Энвер Саидович Токаев Продукт "спортамин" для питания спортсменов
US20090169684A1 (en) * 2007-12-29 2009-07-02 Cresta Andrea K Fitness and exercise enhancing tablet containing protein isolate
EP2098126A1 (en) * 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate Bar

Also Published As

Publication number Publication date
CN102665445A (zh) 2012-09-12
HK1175664A1 (en) 2013-07-12
RU2503269C1 (ru) 2014-01-10
MX2012005646A (es) 2012-06-13
US20130203645A1 (en) 2013-08-08
AU2010323089A1 (en) 2012-05-31
WO2011064373A1 (en) 2011-06-03
IN2012DN04085A (enExample) 2015-08-07
CN102665445B (zh) 2015-03-25
JP5810429B2 (ja) 2015-11-11
EP2327316B1 (en) 2016-11-16
AU2010323089B2 (en) 2014-07-24
PH12012500875A1 (en) 2013-01-07
CA2781764A1 (en) 2011-06-03
BR112012012811A2 (pt) 2015-09-15
EP2327316A1 (en) 2011-06-01
JP2013511970A (ja) 2013-04-11

Similar Documents

Publication Publication Date Title
IN2012DN04085A (enExample)
IN2012DN03632A (enExample)
MX2010008720A (es) Composiciones, metodos y estuches para mejorar la respuesta inmunitaria a una enfermedad respiratoria.
IN2012DN03172A (enExample)
BR112012033422A2 (pt) composições nutricionais de proteína alta, hipocalórica e métodos de usar as mesmas
WO2006110406A3 (en) Compositions comprising probiotic and sweetener components
SG179204A1 (en) Dosage regimen for administering a cd19xcd3 bispecific antibody
MX2009010977A (es) Metodos de administracion de tetrahidrobiopterina, composiciones asociadas y metodos de medicion.
MX2010008726A (es) Composiciones y metodos para influir en la recuperacion a partir de actividad fisica intensa.
EP1670450A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA
MX2010005642A (es) Preparados, metodos y estuches para el tratamiento de la tos.
MX352647B (es) Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato.
UA96076C2 (en) Use of trans-clomiphene
WO2009136219A8 (en) Compositions comprising galactomannan and a process thereof
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
MX2015013749A (es) Metodos para aumentar la sintesis de proteinas musculares despues de entrenamiento simultáneo.
WO2010119346A3 (en) Herbal compositions and methods for enhancing vital energy and athletic performance
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
TW200735863A (en) Dietary compositions for enhancing metabolism and reducing reactive oxygen species
AU2012382949A8 (en) Compositions and methods for treatment of neuropsychological deficits
RU2376888C2 (ru) Биологически активная добавка к пище
UA35209U (ru) Способ продления жизни человека
TW200745132A (en) Novel, acyclically substituted furopyrimidine derivatives and use thereof
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.
WO2011028799A3 (en) Ganglioside transmucosal formulations

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 29 NOV 2017 BY SHELSTON IP

Effective date: 20150203

LAPS Patent lapsed